DigniFI Trial Update: Phase III RCT of Iltamiocel, a Cell Therapy for Obstetric-Related Fecal Incontinence – Where We Are and What’s Next?

Faculty(s)

• 

  Liliana Bordeianou, MD, MPHFASCRS

  Professor of Surgery
  Harvard Medical School; Mass General Brigham Division Colon and Rectal Surgery
  Harvard
  Boston, MA, United States

  Disclosure information not submitted.